Caplin Point Laboratories (NSE:CAPLIPOINT) Short Interest


NSE:CAPLIPOINT Caplin Point Laboratories Ltd NSE:CAPLIPOINT
92 GF Score
Price ₹2,506.40
GF Value ₹2,073.51
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Caplin Point Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:CAPLIPOINT vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caplin Point Laboratories Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Short Interest falls into.


NSE:CAPLIPOINT
92GF Score
Caplin Point Laboratories Ltd NSE:CAPLIPOINT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued. The current stock price of ₹2,506.40 is trading 20.9% above its estimated GF Value™ of ₹2,073.51. GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:CAPLIPOINT:

  • Short Interest:
  • GF Value™: ₹2,073.51 vs. price of ₹2,506.40 (20.9% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Caplin Point Laboratories Business Description

Other Exchanges 524742:India
Address Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
92GF Score

Get the complete analysis for NSE:CAPLIPOINT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,506.40
Price
₹2,073.51
GF Value